Nurse Practitioner Opioid Prescribing Authority: A Comparative Policy Analysis of New Zealand, United States, and Australia

Abstract

Aim

To examine nurse practitioner opioid prescribing authority across three countries, analyzing safety outcomes, workforce distribution patterns, access equity, and service to vulnerable populations using integrated nursing policy and patient-centered access frameworks.

Design

Comparative policy analysis employing Russell and Fawcett's nursing policy framework overlaid on Levesque's access framework.

Methods

We analyzed regulatory documents, national prescribing databases, and published literature from New Zealand, United States, and Australia. Systematic searches identified 14 studies meeting inclusion criteria. We synthesized evidence across four policy analysis levels: efficacy, effectiveness, equity, and social justice. Data collection occurred January through December 2024.

Results

Evidence demonstrated safety and quality outcomes comparable to physician prescribing, with population-level prescribing decreases and no increase in overdose mortality. Nurse practitioners concentrated in rural areas at 34% compared to the 23% national average, with growth occurring during physician workforce decline. Patient panels showed 44% Medicaid coverage compared to 31% for physicians, with 88% versus 71% new Medicaid patient acceptance despite lower reimbursement. However, racial prescribing disparities persisted across all provider types, indicating systemic rather than individual-level determinants.

Conclusion

Expanded prescriptive authority advanced multiple policy objectives while revealing distinctive nursing contributions beyond physician substitution. Workforce distribution and patient panel patterns reflected professional values translating into measurable practice serving vulnerable populations.

Impact

Evidence does not support restrictive policies based on safety concerns. Findings position the nursing workforce as an essential solution for health equity goals, requiring regulatory reform combined with institutional barrier removal and continuing attention to systemic inequities.